Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Ownership  |  Insiders

Stock Quote Today & Recent News Revive Therapeutics Ltd RVVTF


Primary Symbol: C.RVV

Healthcare Biotechnology
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for infectious diseases and medical countermeasures. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:RVV)

CSE Bulletin: MOC Eligibility Update

Newsfile 8 days ago

Revive Therapeutics Announces Closing of Second Tranche of Private Placement

GlobeNewswire September 19, 2025

Revive Therapeutics Announces Extension of Proposed Private Placement

GlobeNewswire September 5, 2025

Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement

GlobeNewswire August 11, 2025

Revive Therapeutics Announces Proposed Private Placement and Debt Settlement

GlobeNewswire July 30, 2025

Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study

GlobeNewswire July 8, 2025

Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity

GlobeNewswire June 26, 2025

Revive Therapeutics Advances with Next-Generation Bucillamine Development

GlobeNewswire June 4, 2025

Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure

GlobeNewswire May 12, 2025
View More News ››

Opinion & Analysis (CSE:RVV)

A Potential Psychedelic and COVID Therapy Play…All in One Stock

Dave Jackson June 18, 2020

Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19

Streetwise Reports June 4, 2020
View More Opinion ››

Bullboard Posts (CSE:RVV)

RE:$EMO - An update from @ArgentoCap - thx.

OOPS - wrong board !
cool888 - July 15, 2025

$EMO - An update from @ArgentoCap - thx.

Well, that’s a wrap! The trial just concluded with the final 2 closing statements today coming from counsels for AMC Mining Iberia (GM...
cool888 - July 15, 2025

I don't even know what this company does

But I'm in for 10'000 shares at a $0.01 CAD.  GLTA ;)
TheWeakendz - January 17, 2025

Posted Jan 9, 2025 By Revive Theraputics Ltd.

Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure Over the next few weeks data will...
G1945V - January 9, 2025

Keep an eye on XBOT

Realbotix.  Do your own DD
TheWeakendz - December 9, 2024

Psilocybin in the Treatment of Neurological Brain Injury

https://stockhouse.com/news/press-releases/2024/11/12/revive-therapeutics-announces-publication-demonstrating-novel-therapeutic
ElBorto - November 23, 2024
View more Bullboard ››

Atlas Salt Inc.

Atlas Salt Inc.

Atlas Salt Inc. is a Canada-based mineral exploration company. The Company is engaged in the evaluation and exploration of ...
View More »